CompletedPhase 1NCT00938288
A Study of KW-3357 in Congenital Antithrombin Deficiency
Studying Hereditary thrombophilia due to congenital antithrombin deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Kyowa Kirin Co., Ltd.
- Principal Investigator
- Beverley Hunt, FRCP, FRCPath MD, M.DSt Thomas' Hospital, London, UK
- Intervention
- KW-3357(drug)
- Enrollment
- 16 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2009 – 2011
Study locations (8)
- Department of Haemotogy, Haemastasy, Oncology and Stem Cell Transplantation, Hannover Medical School, Hanover, Germany
- Center for Thrombosis and Haemostasis, Malmo University Hospital, Malmo, Sweden
- Dept Obst Gyn/Section for Women and Child Health/Clinical Trial Unit, Karolinska University Hospital, Stockholm, Sweden
- Treliske, Haematology Clinic, Royal Cornwall Hospital, Truro, Cornwall, United Kingdom
- Bristol Haemophia Care Centre, Bristol Haemotology and Oncology Centre, Bristol, United Kingdom
- Department of Haemotology, Glasgow Royal Infirmary, Glasgow, United Kingdom
- Kings College, Dept of Haematology, Lupus & Pathology Guy's and St Thomas Trust, St Thomas Hospital, Ctr for Haemostasis and Thrombosis (the Haemophia Reference Ctr), London, United Kingdom
- University College London Hospital NHS Trust, London, United Kingdom
Collaborators
Kyowa Hakko Kirin UK, Ltd.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00938288 on ClinicalTrials.gov